Improved analysis
Prostate cancer is the most common cancer in men in western countries and is on the rise again.
Prostate cancer is the most common cancer in men in western countries and is on the rise again.
An article published in 2008 determined that capillary electrophoresis mass spectrometry urinary proteome analysis was very accurate in detecting prostate cancer. The same research team has now applied this test in clinical practice and its cost-effectiveness.1
The urinary proteome analysis test was performed on 211 outpatients who had been referred to with suspicious prostate-specific antigen or after digital rectal examination. In 184 data about their follow up and the test results were available for analysis. Prostate cancer was detected by biopsy in 49 cases. The test correctly recognized 42 out of 49 cases, which is a sensitivity of 86%. Out of 135 prostate cancer-negative patients, 79 had a negative response in the urinary proteome analysis, a specificity of 59%. Negative and positive predictive values were 92% and 43%, respectively. In addition, the urinary proteome analysis results agreed in 65.7% of the follow-up reference results.
The team also analysed how cost-effective the procedure was and they concluded that their method was more beneficial than the biopsy approach as fewer biopsies were performed and fewer complications arose as a result.This procedure has many benefits for the patient, including its non‑invasive nature, and it was concluded that the test is a helpful addition to prostate cancer diagnostics.
1. W. Schöfer et al, International Journal of Urology, 19(2), 118–125 (2012).
This story originally appeared in The Column. Click here to view that issue.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
PFAS Identified in Smartwatch and Fitness Bands Using LC–MS/MS
January 28th 2025“Forever chemicals” per- and polyfluoroalkyl substances (PFAS) have been found in smartwatch and fitness bands and analyzed using liquid chromatography tandem mass spectrometry (LC–MS/MS) and direct total oxidative precursor (dTOP) assay.
